metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]
metoclopramide
RxCUI: 2380570
What the CMS Formulary Data Shows for metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]
Per the CMS 2026 Part D formulary file, metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] (RxNorm concept RXCUI 2380570, generic name metoclopramide) appears on 1 distinct formulary file spanning 1 Medicare Part D plan offering - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 2, with a cross-plan average of Tier 2.
Real-world access to metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 402,098 Part D beneficiaries filled metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] in 2023, with total plan-and-beneficiary spending of $10,453,313 and an average per-beneficiary annual cost of $26.00. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 1
- Coverage rate
- 0%
- Tier range
- Tier 2, Generic
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 402,098
- Total spending
- $10,453,313
- Avg per beneficiary
- $26.00
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]
1 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CalOptima Health OneCare Complete (HMO D-SNP) | ORANGE COUNTY HEALTH AUTHORITY | T2 | Yes | $0 | CA |
Frequently Asked Questions
Is metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] covered by Medicare Part D?
Yes, metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] is covered by 1 Medicare Part D plans (0% of all Part D formularies).
What tier is metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] on Medicare Part D plans?
metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] averages Tier 2 across Part D plans, ranging from Tier 2 to Tier 2.
Does metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] require prior authorization?
100% of Part D formularies require prior authorization for metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]. Step therapy: 0%. Quantity limits: 100%.
How much does Medicare spend on metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]?
In 2023, total Medicare Part D spending on metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti] was $10,453,313, covering 402,098 beneficiaries. The average spend per beneficiary was $26.00.
Read our methodology - how this data is sourced, computed, and verified.